| Literature DB >> 30403718 |
Pengfei Wu1,2, Guojun Dai1,2, Fuxiang Chen1,2, Lan Chen1,2, Tao Zhang1,2, Kaizhou Xie1,2, Jinyu Wang1,2, Genxi Zhang1,2.
Abstract
Chicken is widely favored by consumers because of some unique features. The leg muscles occupy an important position in the market. However, the specific mechanism for regulating muscle growth speed is not clear. In this experiment, we used Jinghai yellow chickens with different body weights at 300 days as research subjects. The chickens were divided into fast- and slow-growing groups, and we collected leg muscles after slaughtering for use in RNA-seq. After comparing the two groups, 87 differentially expressed genes (DEGs) were identified (fold change ≥ 2 and FDR < 0.05). The fast-growing group had 42 up-regulated genes and 45 down-regulated genes among these DEGs compared to the slow-growing group. Six items were significantly enriched in the biological process: embryo development ending in birth or egg hatching, chordate embryonic development, embryonic skeletal system development, and embryo development as well as responses to ketones and the sulfur compound biosynthetic process. Two significantly enriched pathways were found in the KEGG pathway analysis (P-value < 0.05): the insulin signaling pathway and the adipocytokine signaling pathway. This study provides a theoretical basis for the molecular mechanism of chicken growth and for improving the production of Jinghai yellow chicken.Entities:
Mesh:
Year: 2018 PMID: 30403718 PMCID: PMC6221307 DOI: 10.1371/journal.pone.0206131
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Analysis of differences between the two groups.
| Traits | Low weight | High weight |
|---|---|---|
| Live weight(g) | 1353.33±14.53A | 2553.33±97.31B |
| Leg muscle weight(g) | 94.27±2.27a | 182.73±10.74b |
Note: Means in the same row with different lowercase letters indicate significant differences (P < 0.05), with different capital letters also indicating significant differences (P < 0.01).
Sequencing data.
| Samples | Clean reads | Clean bases | GC Content | %≥Q30 |
|---|---|---|---|---|
| T1 | 25,684,671 | 5,187,451,860 | 52.17% | 80.15% |
| T2 | 27,925,040 | 5,639,352,036 | 53.68% | 80.30% |
| T3 | 23,379,518 | 4,721,718,610 | 52.55% | 80.09% |
| T4 | 22,362,504 | 4,516,161,206 | 53.60% | 81.13% |
| T5 | 27,526,111 | 5,559,154,066 | 52.38% | 80.24% |
| T6 | 25,524,976 | 5,154,259,598 | 53.02% | 81.29% |
Note: Clean reads: total number of pair-end reads in the clean data; Clean bases: total number of bases in the clean data; GC content: percentage of G and C bases in the clean data; % ≥ Q30: the percentage of Q30 base.
Comparison results.
| Sample | Total Reads | Mapped Reads | Uniq Mapped Reads | Multiple Mapped Reads | Reads Mapped to ‘+’ | Reads Mapped to ‘-‘ |
|---|---|---|---|---|---|---|
| T1 | 51,369,342 | 37,735,076 (73.46%) | 36,331,091 (70.73%) | 1,403,985 (2.73%) | 18,795,619 (36.59%) | 18,654,167 (36.31%) |
| T2 | 55,850,080 | 40,489,093 (72.50%) | 38,865,457 (69.59%) | 1,623,636 (2.91%) | 20,142,523 (36.07%) | 20,014,964 (35.84%) |
| T3 | 46,759,036 | 34,530,849 (73.85%) | 33,188,302 (70.98%) | 1,342,547 (2.87%) | 17,206,777 (36.80%) | 17,085,774 (36.54%) |
| T4 | 44,725,008 | 32,646,136 (72.99%) | 31,635,623 (70.73%) | 1,010,513 (2.26%) | 16,263,304 (36.36%) | 16,153,912 (36.12%) |
| T5 | 55,052,222 | 40,970,657 (74.42%) | 39,726,232 (72.16%) | 1,244,425 (2.26%) | 20,439,448 (37.13%) | 20,286,215 (36.85%) |
| T6 | 51,049,952 | 37,953,225 (74.35%) | 36,622,732 (71.74%) | 1,330,493 (2.61%) | 18,885,017 (36.99%) | 18,787,799 (36.80%) |
Note: Total Reads: the number of single-end reads in the clean data; Mapped Reads: the number of reads on the reference genome and the percentage of mapped reads in the clean reads; Uniq Mapped Reads: the number of reads compared to the only location of the reference genome and the percentage of clean reads; Multiple Map Reads: the number of reads compared to the multiple locations of the reference genome and the percentage of multiple map reads in the clean reads; Reads Map to ‘+’: the number of reads compared to the positive-strand and the percentage of clean reads. Reads Map to Reads Map to ‘-‘: the number of reads compared to the negative-strand and the percentage of clean reads.
Fig 1Volcano plot.
Fig 2MA plot.
Fig 3Cluster analysis of DEGs.
Significantly enriched biological process terms.
| Term ID | Term | Count | P-Value | Genes |
|---|---|---|---|---|
| GO:0009792 | embryo development ending in birth or egg hatching | 7 | 0.001055 | NLE1, WNT9A, KIAA1217, SLC35D1, SHROOM3, EYA1, MSTN |
| GO:0043009 | chordate embryonic development | 6 | 0.005054 | NLE1, WNT9A,KIAA1217, SLC35D1, SHROOM3, EYA1 |
| GO:0048706 | embryonic skeletal system development | 4 | 0.008883 | WNT9A, KIAA1217, SLC35D1, EYA1 |
| GO:1901654 | response to ketone | 3 | 0.027751 | ABHD2, PPKAA2, MSTN |
| GO:0009790 | embryo development | 7 | 0.038256 | NLE1, WNT9A, KIAA1217, SLC35D1, SHROOM3, EYA1, MSTN |
| GO:0044272 | sulfur compound biosynthetic process | 3 | 0.039303 | GCLM, SLC35D1, HS3ST5 |
Fig 4Top 20 genes of pathway enrichment.
Significantly enriched pathway.
| Term | Count | P-Value | Genes |
|---|---|---|---|
| gga04910:Insulin signaling pathway | 4 | 0.021645 | SH2B adaptor protein 2(SH2B2); protein kinase, AMP-activated, alpha 2 catalytic subunit(PRKAA2); protein kinase, AMP-activated, gamma 3 non-catalytic subunit(PRKAG3); insulin receptor substrate 2(IRS2). |
| gga04920: | 3 | 0.04416 | protein kinase, AMP-activated, alpha 2 catalytic subunit(PRKAA2); protein kinase, AMP-activated, gamma 3 non-catalytic subunit(PRKAG3); insulin receptor substrate 2(IRS2) |
Fig 5Expression level of nine DEGs detected by RNA-seq and qRT-PCR.